A double-blind comparison of meptazinol with pentazocine and placebo in cancer pain.
Two consecutive double-blind, crossover, single-administration trials have shown that intramuscular meptazinol, a new opioid-antagonist drug, is superior to placebo and equivalent ot pentazocine in relieving chronic pain due to cancer.